ClinicalTrials.Veeva

Menu

Superficial Cervical Plexus Block for Improved Outcomes in Pediatric Otolaryngologic Surgery

University of Minnesota (UMN) logo

University of Minnesota (UMN)

Status and phase

Suspended
Phase 4

Conditions

Otolaryngologic Surgery

Treatments

Drug: ropivacaine
Drug: Saline

Study type

Interventional

Funder types

Other

Identifiers

NCT06023329
ANES-2023-31691

Details and patient eligibility

About

Literature on the use of superficial cervical plexus blocks for ear surgery is sparse in general, and almost non-existent in the pediatric population. Overall, literature review supports the safety of performance of this block but there is minimal published literature on its utility despite anecdotal evidence of benefit. This study, especially its prospective randomized nature will allow for expansion of the evidence for or against addition of this block to the care of pediatric patients undergoing ear surgery. The purpose of this study is to determine if SCPB plus standard practices provides superior pain control, as measured by reduced opiate consumption, compared to standard practices alone when performed on pediatric patients undergoing surgery on the ear and mastoid process.

Enrollment

36 estimated patients

Sex

All

Ages

3 months to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age: <18 years and >3 months
  • Surgical procedure: Unilateral cochlear implant or tympanomastoidectomy

Exclusion criteria

  • Preoperative opiate use within the last 30 days
  • Bilateral surgery
  • No English speaking caregiver
  • Parental/patient refusal
  • Severe preoperative respiratory compromise
  • Allergy to ropivacaine
  • Coagulopathy: Defined by INR&gt;1.5 or Platelet count &lt;100k
  • Current Infection at site of injection
  • VP Shunt on side of surgical procedure
  • Pregnant patients: determined by patient history and available laboratory data. Patients will not be required to have pregnancy testing done if not otherwise indicated.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

36 participants in 2 patient groups, including a placebo group

Group1
Experimental group
Treatment:
Drug: ropivacaine
Group 2
Placebo Comparator group
Treatment:
Drug: Saline

Trial contacts and locations

1

Loading...

Central trial contact

Candace Nelson

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems